Navigation Links
Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Date:10/30/2007

MRSA Scorecard Provides Hospital-Wide View of MRSA Infections

DUBLIN, Ohio, Oct. 30 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced a new service to help hospitals combat methicillin-resistant staphylococcus aureus (MRSA) infections that are responsible for an estimated 94,000 life-threatening conditions and 18,650 deaths annually in the U.S.(1)

Cardinal Health is deploying a new MRSA Scorecard to hospitals that monitor infections using the company's MedMined(TM) services. The new scorecard provides a hospital-wide view of MRSA, allowing infection control practitioners to track the types and locations of MRSA infections throughout the hospital. The MRSA Scorecard uses Cardinal Health's patent-pending Nosocomial Infection Marker (NIM) methodology, which allows hospitals to identify patients who have tested positive for the bacteria and distinguish between those who likely acquired the infection in the hospital. Through this real-time view, hospitals can rapidly dispatch resources to limit the spread of infections.

The MRSA scorecard is available to all hospitals using MedMined(TM) services and will be offered free of charge for four months through a sponsorship program from BD (Becton, Dickinson and Company).

"The MRSA Scorecard will help hospitals make evidence-based decisions about the most appropriate way to respond to MRSA in their facilities," said Patrick Hymel, MD, vice president and medical director for Cardinal Health's MedMined(TM) services. "This new tool enables a comprehensive and consistent approach to preventing these dangerous infections."

Cardinal Health provides nearly 250 major U.S. hospitals with automated electronic infection prevention surveillance and management systems designed to identify health care associated infections (HAIs) in real time, enabling immediate interventions to prevent subsequ
'/>"/>

SOURCE Cardinal Health
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
6. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
7. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
8. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
9. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
10. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
11. Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-Fir...hat Dr. Michael J. McKelvey, the Company,s Preside...tive Vice President and CFO, are scheduled to pres...onference at 1:30 PM EST on December 1, 2009 in Ne...y access the presentation by visiting the Company,...
(Date:11/25/2009)... , BRIDGEWATER, N.J., Nov. 25 ...® (etravirine) tablets, a non-nucleoside reve...the only NNRTI specifically indicated for use in t...irologic failure with HIV-1 strains resistant to a...e traditional approval is based on 48-week data fr...
(Date:11/25/2009)... , RANCHO CORDOVA, Calif., Nov. 25 /PRNewswir... of American Pacific Corporation (Nasdaq: APFC ) ... Responsibility and Sustainability Award at the An...the California Manufacturers and Technology Associ...tion (IEA) and the Chemical Industry Council of Ca...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 1Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 1Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 3Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 4FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 1FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 2FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 3
...26 The Blumenthal,Cancer Center at Carolinas Medi...he Moffitt Cancer Center in a study that could lea...of cancer. CMC is the first hospital system,outsid... Over the next five years, CMC will enroll more t...e collecting tissue samples, medical histories,and...
...26 Pharmacopeia,(Nasdaq: PCOP ), an innovator in...cule therapeutics, today announced the completion ... 2a clinical study of PS433540 (DARA),the company,...f the Phase,2a randomized, double-blind, placebo-c... efficacy and safety of 200 and 500 mg of PS433540...
Other Medicine Technology:CMC, Moffitt Partner to Study Cancer 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4
(Date:11/30/2009)...O A large proportion of patients who undergo abdo...dicated and unnecessary additional image acquisiti...re, according to a study presented today at the an...America (RSNA). , "It is the responsibility of a...ensure that the dosage is as low as reasonably ach...
(Date:11/29/2009)..., ATLANTA, Nov. 29 The followin...livest Securities Research, Inc. ,, Intellivest...stered investment advisor, has published a Report ... in the pharmaceutical, biotechnology and medical ...heir clients manage, process and submit medical im...
(Date:11/29/2009)...ng someone get blamed for something leads to more ... , SUNDAY, Nov. 29 (HealthDay News) -- The bl... even when the target is innocent. , Researcher... else for a problem, even if it,s an unfair accusa...g others, too. , "When we see others protectin...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welcome to...solution for the clinical routine from Siemens H...Communications System (PACS) from Siemens where ... syngo .plaza is poised to change the way mul...ling this innovation at the 95th Scientific Asse...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall...any"), a supplier of precision technology products...n annual meeting of the Company,s shareholders has...ime and location of the meeting will be announced ...ny received a requisition notice from Stephen Bers...
Breaking Medicine News(10 mins):Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2
...fering from Insomnia , , LOS ANGELES, March 31 F...ng and negative impact than a lost night,s sleep. ...nd the endless array of other daily responsibiliti...nfortunately, many women are doing just that, and ...
...vides Extensive Services & Support , , SAN FR...xperienced provider of in home support and recover... its San Francisco location. Interim HomeStyle Se...r from illness. , , The San Francisco location w...
... top, industry employers across North Carolina , ...h 31, 2009 -- BioSpace , the leading resource for...e seventh edition of the Bio NC Hotbed Campaign ...Research Triangle Park and other areas of North Ca...
...FACP is in the private practice of internal medici... the best doctors in New Jersey by New Jersey Mont...;Top Doctor" accolade for the third consecuti... year in the November, 2008 issue of New Jersey Mo...
...laxoSmithKline plc (NYSE: GSK ) has entered into..., Nasdaq: SHPGY ) for Vy v a n s e(R) , to...lt Attention Deficit Hyperactivity Disorder (ADHD)...in discovering and developing medicines to treat p...
...nuts sold in at least 31 states , , MONDAY...Administration officials said Monday night that th...on that could involve 1 million pounds of pistachi... said. , "We are not dealing with an outbreak here...
Other Medicine News:Health News:Tired of Sleepless Nights? 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:BioSpace Launches the 2009 Bio NC™ Hotbed Campaign 2Health News:Dr Howard Holtz Named New Jersey Top Doctor for Third Consecutive Year 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 3Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 4Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 5Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 6Health News:FDA Investigating Salmonella-Tainted Pistachios 2
ABL800 FLEX Blood Gas Analyzer
Flatbed Agitator PFS84
Flatbed Agitator PFS42
...telet agitators offer a wide range of storage capa... storage platform to agitate smoothly, eliminating...ueak. Sturdy, one-piece perforated drawers with no...ation for your platelets., ,i.Series platelet ...
Medicine Products: